OS. (A) OS after t-AML/MDS diagnosis in patients undergoing aSCT (dashed line) or not undergoing aSCT (solid line); (B) OS after t-AML/MDS diagnosis in patients undergoing aSCT with an unrelated donor (dashed line) or a related donor (solid line).